Ranibizumab or Aflibercept for Diabetic Macular Edema
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 127 (5) , 608-615
Abstract
No abstract availableKeywords
Funding Information
- Macular Disease Foundation Australia
This publication has 23 references indexed in Scilit:
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular EdemaNew England Journal of Medicine, 2015
- Intravitreal Aflibercept for Diabetic Macular EdemaOphthalmology, 2014
- Is There Risk of Stroke with Aflibercept?Ophthalmology, 2014
- EFFICIENT CAPTURE OF HIGH-QUALITY DATA ON OUTCOMES OF TREATMENT FOR MACULAR DISEASESRetina, 2014
- One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular EdemaOphthalmology, 2012
- Ranibizumab for Diabetic Macular EdemaOphthalmology, 2012
- Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)Diabetes Care, 2010
- Fast Stable Restricted Maximum Likelihood and Marginal Likelihood Estimation of Semiparametric Generalized Linear ModelsJournal of the Royal Statistical Society Series B: Statistical Methodology, 2010
- Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research DesignsNew England Journal of Medicine, 2000
- Photocoagulation for Diabetic Macular EdemaArchives of Ophthalmology (1950), 1985